Development of Novel Jak3 Inhibitors for the Treatment of Autoimmunity (DPFS) (Joint with University of Glasgow and Harvard University)

Project Details

StatusFinished
Effective start/end date1/02/1631/03/18

Funding

  • Medical Research Council (MR/M025233/1): £283,528.00